Steven D. Ertel
2013
In 2013, Steven D. Ertel earned a total compensation of $901.8K as Executive Vice President and Chief Operating Officer at Acceleron Pharma, a 75% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $141,075 |
|---|---|
| Option Awards | $447,244 |
| Salary | $313,500 |
| Total | $901,819 |
Ertel received $447.2K in option awards, accounting for 50% of the total pay in 2013.
Ertel also received $141.1K in non-equity incentive plan and $313.5K in salary.
Rankings
In 2013, Steven D. Ertel's compensation ranked 7,098th out of 12,286 executives tracked by ExecPay. In other words, Ertel earned more than 42.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,098 out of 12,286 | 42nd |
Division Manufacturing | 2,527 out of 4,612 | 45th |
Major group Chemicals And Allied Products | 777 out of 1,462 | 47th |
Industry group Drugs | 578 out of 1,156 | 50th |
Industry Biological Products, Except Diagnostic Substances | 91 out of 196 | 54th |
Source: SEC filing on April 15, 2016.
Ertel's colleagues
We found four more compensation records of executives who worked with Steven D. Ertel at Acceleron Pharma in 2013.